Section 5: Patient Safety and Quality Assurance 2019
DOI: 10.1136/ejhpharm-2019-eahpconf.530
|View full text |Cite
|
Sign up to set email alerts
|

5PSQ-097 Triple whammy interaction: improving patients’ safety

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
1
1
0
1
Order By: Relevance
“…In a scoping review, the clinical validation of several CDSSs for drug-related problems revealed a sensitivity of 28%–85% and a specificity of 42–75% [ 36 ], though these were not studies of CDSS for TW management. A general acceptance rate above 60% is suggested for action-oriented interventions [ 37 ]; our TW algorithm compliance rate was 77.7%, which compares favourably with this standard and with the acceptance rates reported for primary care TW CDSSs (30–82%) [ 26 , 28 , 29 ]. The acceptance rate differed between the alerts and was highest within patients with a kidney function below 30 ml/min/1.73m2.…”
Section: Discussionsupporting
confidence: 71%
See 1 more Smart Citation
“…In a scoping review, the clinical validation of several CDSSs for drug-related problems revealed a sensitivity of 28%–85% and a specificity of 42–75% [ 36 ], though these were not studies of CDSS for TW management. A general acceptance rate above 60% is suggested for action-oriented interventions [ 37 ]; our TW algorithm compliance rate was 77.7%, which compares favourably with this standard and with the acceptance rates reported for primary care TW CDSSs (30–82%) [ 26 , 28 , 29 ]. The acceptance rate differed between the alerts and was highest within patients with a kidney function below 30 ml/min/1.73m2.…”
Section: Discussionsupporting
confidence: 71%
“…As such, this risky drug combination is often not detected by conventional CDSSs. Several specific algorithms have been developed for primary care [ 26 – 30 ]. Notably, like many drug-drug interactions, a TW prescription is not strictly contraindicated.…”
Section: Introductionmentioning
confidence: 99%
“…Siguiendo este rumbo, en el Servicio Navarro de Salud-Osasunbidea (SNS-O) se han abordado por múltiples vías los riesgos de los AINE y la desprescripción de benzodiacepinas. Se han empleado boletines 8 , 9 , acciones formativas, alertas en la receta electrónica 10 e información para pacientes 11 .…”
unclassified